NR4A1 has been found to be overexpressed in a spectrum of solid tumors, such as breast, pancreatic, ovarian, colon, endometrial, and rhabdomyosarcomas [45,46,47,48,49]. This evidence concerns the gene NR4A1 and rhabdomyosarcoma.